Literature DB >> 31392582

Optimising antimicrobial therapy through the use of Bayesian dosing programs.

M L Avent1,2, B A Rogers3,4.   

Abstract

The optimisation of antibiotic dosing therapy with therapeutic drug monitoring is widely recommended. The aim of therapeutic drug monitoring is to help the clinician to achieve target pharmacokinetic/pharmacodynamic parameters, maximising efficacy and minimising toxicity. Computerised programs, utilising the Bayesian estimation procedures, are able to achieve target concentrations in a greater percentage of patients earlier in the course of therapy compared to linear regression analysis and population methods. This article summarises various methods for dose optimisation of antibiotics with a focus on Bayesian programs.

Entities:  

Keywords:  Antibiotics; Bayesian statistics; Pharmacodynamics; Pharmacokinetics; Software

Mesh:

Substances:

Year:  2019        PMID: 31392582     DOI: 10.1007/s11096-019-00886-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


  27 in total

1.  Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens.

Authors:  S B Duffull; C M Kirkpatrick; E J Begg
Journal:  Br J Clin Pharmacol       Date:  1997-02       Impact factor: 4.335

2.  A Bayesian approach to tracking patients having changing pharmacokinetic parameters.

Authors:  David S Bayard; Roger W Jelliffe
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-02       Impact factor: 2.745

3.  Comparison of gentamicin dose estimates derived from manual calculations, the Australian 'Therapeutic Guidelines: Antibiotic' nomogram and the SeBA-GEN and DoseCalc software programs.

Authors:  Mitali Mohan; Kevin T Batty; Jennifer A Cooper; Richard E Wojnar-Horton; Kenneth F Ilett
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

4.  Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of gentamicin and vancomycin data collected from patients undergoing cardiothoracic surgery.

Authors:  Iona Macdonald; Christine E Staatz; Roger W Jelliffe; Alison H Thomson
Journal:  Ther Drug Monit       Date:  2008-02       Impact factor: 3.681

5.  Comparative Evaluation of the Predictive Performances of Three Different Structural Population Pharmacokinetic Models To Predict Future Voriconazole Concentrations.

Authors:  Andras Farkas; Gergely Daroczi; Phillip Villasurda; Michael Dolton; Midori Nakagaki; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

6.  Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis.

Authors:  Stefanie Hennig; Franziska Holthouse; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

7.  Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.

Authors:  Minyon L Avent; Junlu Teoh; Judith Lees; Kerena A Eckert; Carl M Kirkpatrick
Journal:  Ther Drug Monit       Date:  2011-10       Impact factor: 3.681

Review 8.  Pharmacokinetic issues for antibiotics in the critically ill patient.

Authors:  Jason A Roberts; Jeffrey Lipman
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

9.  Bayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis.

Authors:  Michael A Barras; David Serisier; Stefanie Hennig; Katrina Jess; Ross L G Norris
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 10.  Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.

Authors:  Jason A Roberts; Mohd H Abdul-Aziz; Jeffrey Lipman; Johan W Mouton; Alexander A Vinks; Timothy W Felton; William W Hope; Andras Farkas; Michael N Neely; Jerome J Schentag; George Drusano; Otto R Frey; Ursula Theuretzbacher; Joseph L Kuti
Journal:  Lancet Infect Dis       Date:  2014-04-24       Impact factor: 25.071

View more
  8 in total

1.  Model-Optimized Fluconazole Dose Selection for Critically Ill Patients Improves Early Pharmacodynamic Target Attainment without the Need for Therapeutic Drug Monitoring.

Authors:  Indy Sandaradura; Jessica Wojciechowski; Deborah J E Marriott; Richard O Day; Sophie Stocker; Stephanie E Reuter
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

Review 2.  Optimizing antimicrobial use: challenges, advances and opportunities.

Authors:  Timothy M Rawson; Richard C Wilson; Danny O'Hare; Pau Herrero; Andrew Kambugu; Mohammed Lamorde; Matthew Ellington; Pantelis Georgiou; Anthony Cass; William W Hope; Alison H Holmes
Journal:  Nat Rev Microbiol       Date:  2021-06-22       Impact factor: 60.633

3.  Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection.

Authors:  Sylvain Goutelle; Anne Conrad; Cécile Pouderoux; Evelyne Braun; Frédéric Laurent; Marie-Claude Gagnieu; Sabine Cohen; Jérôme Guitton; Florent Valour; Tristan Ferry
Journal:  Front Med (Lausanne)       Date:  2021-03-31

4.  Chinese ICU physicians' knowledge of antibiotic pharmacokinetics/pharmacodynamics (PK/PD): a cross-sectional survey.

Authors:  Wenchao Mao; Difan Lu; Jia Zhou; Junhai Zhen; Jing Yan; Li Li
Journal:  BMC Med Educ       Date:  2022-03-14       Impact factor: 2.463

5.  A Free Open-Source Bayesian Vancomycin Dosing App for Adults: Design and Evaluation Study.

Authors:  Thomas Oommen; Anirudh Thommandram; Adam Palanica; Yan Fossat
Journal:  JMIR Form Res       Date:  2022-03-30

Review 6.  Impact on Antibiotic Resistance, Therapeutic Success, and Control of Side Effects in Therapeutic Drug Monitoring (TDM) of Daptomycin: A Scoping Review.

Authors:  Carolina Osorio; Laura Garzón; Diego Jaimes; Edwin Silva; Rosa-Helena Bustos
Journal:  Antibiotics (Basel)       Date:  2021-03-05

7.  Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin.

Authors:  Justine Heitzmann; Yann Thoma; Romain Bricca; Marie-Claude Gagnieu; Vincent Leclerc; Sandrine Roux; Anne Conrad; Tristan Ferry; Sylvain Goutelle
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

8.  Personalized Antibiotic Therapy for the Critically Ill: Implementation Strategies and Effects on Clinical Outcome of Piperacillin Therapeutic Drug Monitoring-A Descriptive Retrospective Analysis.

Authors:  Schrader Nikolas; Riese Thorsten; Kurlbaum Max; Meybohm Patrick; Kredel Markus; Surat Güzin; Scherf-Clavel Oliver; Strate Alexander; Pospiech Andreas; Hoppe Kerstin
Journal:  Antibiotics (Basel)       Date:  2021-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.